Pharming Group appoints former Novartis USA President Fabrice Chouraqui as New CEO
Source: SeekingAlpha
2025-01-21 02:11:24 ET
- Pharming Group offers to buy Sweden's Abliva for SEK 0.45/shr
- Seeking Alpha’s Quant Rating on Pharming
- Historical earnings data for Pharming
Read the full article on Seeking Alpha
For further details see:
Pharming Group appoints former Novartis USA President Fabrice Chouraqui as New CEO
Pharming Group N.V.
NASDAQ: PHAR
PHAR Trading
3.28% G/L:
$16.36 Last:
5,035 Volume:
$16.25 Open:
PHAR Latest News
PHAR Stock Data
$1,106,258,522
65,794,170
N/A
5
N/A
Biotechnology & Life Sciences
Healthcare
NL
Leiden
